Carbon Lehigh Intermediate Unit #21 Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 912 Coal Region Way, Lansford, PA 18232 Phone: 610-769-4111 |
Pcs Mental Health Llc Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 49 S Walnut St, Lansford, PA 18232 Phone: 215-997-9959 |
Panther Valley School District Psychologist - School Medicare: Not Enrolled in Medicare Practice Location: 1 Panther Way, Lansford, PA 18232 Phone: 570-645-3176 Fax: 570-645-2507 |
Holistic Therapeutic Outreach Services, Llc Social Worker Medicare: Not Enrolled in Medicare Practice Location: 50 W Ridge St, Lansford, PA 18232 Phone: 570-805-4711 |
News Archive
Tris Pharma, a specialty pharmaceutical company that develops innovative drug delivery technologies, announced today that the US Food and Drug Administration (FDA) has accepted its Extended Release Carbinoxamine Oral Suspension NDA for the treatment of allergies in kids two years and older. If approved, Tris Pharma's Extended Release Suspension will provide an alternative to the currently available immediate release formulations.
Src (short for sarcoma) is a family of proto-oncogenic tyrosine kinases active in many cancer tumors, including medulloblastoma, the most common malignant cancer in children. Src represents one of the most promising targets for cancer therapy.
MEDIAN Technologies, a leading medical imaging software developer and service provider for oncology clinical trials, announced today its participation in the 2012 ASCO annual conference, to be held next June 1-5, in Chicago, IL, USA.
One in five young people have fatty liver disease (steatosis), with one in 40 having already developed liver scarring (fibrosis), research published today [15 January] has found.
› Verified 6 days ago